Dyslipidemia and Treatments
Mark your calendars now to experience the premiere global event focusing on improving health by championing scientific discovery and practice-changing educational content.
Begin your #AHA22 experience by submitting an abstract April 13 – June 9, 6:00 PM CST. We can’t wait to see you this November!
Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!
Members and attendees can now access informative, practice-changing sessions or earn CE credits for free -- through a different link. And nonmembers can purchase our Sessions package or our special CE bundle.
The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. The council nurtures basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavioral change.
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.
SOLOIST WHF and SCORED Results
Investigator Deepak Bhatt, MD summarizes the results of 2 trials on dual SGT1 and SGT2 inhibition, which he presented during Scientific Sessions 2020.